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To the Editor:
COVID-19 infection results in an elevated risk of pulmonary
complications and mortality in the hypertensive, diabetic, and
old age individuals and patients with cardiovascular or pul-
monary diseases. This situation is critical in the African
American (AA) population. As a paradigmatic representation
of the state is of interest, mentioning that the morbidity and
mortality rates by COVID-19 in AA are the highest among
many other populations, as well as the mortality rate is 6-fold
higher compared with white people [1].
There are many health disparities in AA like high
incidence rates of obesity, diabetes, high blood pressure,
cardiovascular and renal diseases, among others. The usual
explanation for these differences is the low socioeconomic
status and educational levels, the social environment, lifestyle
habits, and less access to health care services. However, there
are pieces of evidence that these non-favorable conditions are
not enough, and there are other influential factors that may
help to a better approach to the real problem, like some
genetic polymorphism and epigenetic-driven changes [2].
In this sense, of medical relevance are the differences in
renin-angiotensin-aldosterone systems (RAAS), renal sodium
manages [3], and -of interest for this letter-, the low levels of
serum vitamin D [4, 5] (Fig. 1).
AA people have a high genetic ability to retain salt [6].
The sodium retention observed in black people causes the
inhibition of systemic RAAS (sRAAS) by negative feedback.
The high prevalence of high blood pressure levels in this
population is a clinical manifestation of these disarrange-
ments. Also, high blood pressure would be one of the main
risk factors for SARs-CoV-2 infection [7], and RAAS would
be an essential part of the pulmonary tissue injury [8].
AA people use drugs that blockade RAAS despite its
lower reduction in blood pressure compared whit its use in
non AA patients, because of its protective cardiovascular
effects. A recent publication had proposed the hypothesis
that RAAS blocker drugs, could act as a risk factor
for patients with SARS-CoV-2 infection, by increasing
synthesis of angiotensin-converting enzyme 2 (ACE2) [9].
Indeed, there are experimental works that have demon-
strated that the use of these drugs increases ACE2 levels
[10], being the ACE2 receptor used by SARS-CoV-2 to
enter and injury the cells [11]. An immediate reaction from
the medical community and scientific societies, together
with the appearance of the results of several studies,
confirmed that blocking the RAAS was not harmful and
could even be beneficial for the evolution of infected
patients. After entering the cells, SARS-CoV-2 reduces
protective ACE2 activity and function inducing, in turn,
damage to pulmonary parenchyma. At the same time, the
consequent imbalance of ACE/ACE2 enhances the harm-
ful action of angiotensin II on the lungs of the infected
patients [12].
Complementary, there is an association between high
serum vitamin D levels and benefits on many aspects of
health, including viral infection. Most of the AA people
lack normal serum levels of vitamin D, and the average of
their serum levels is considerably lower than other popu-
lations [5] (Fig. 1).
Additionally, low serum vitamin D levels are associated
with a higher number and severity of respiratory infections
than people with normal levels [13]. Clinical trials have
shown that vitamin D administration reduces respiratory
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infections in healthy people, as well as in patients with
chronic respiratory diseases, including cases with viral
infection by COVID-19 [14]. It is known that vitamin D
exerts this protective effect on respiratory tract mainly
through three mechanisms: the preservation of tight junc-
tions to avoid the immune cells infiltration of into the lungs
and other respiratory organs, the destruction of enveloped
viruses by the stimulation of cathelicidin and defensins,
and the decrease in pro-inflammatory cytokines synthesis
by the immune system modulation [15]. Moreover, vitamin
D has been suggested as a natural antioxidant and anti-
inflammatory able to enhance the prognosis of lung
pathologies [16]. Additionally, the combined actions of
vitamin D and other endogenous molecules with strong
antioxidant properties such as melatonin may provide a
synergistic effect against COVID-19 infection and its lethal
consequences [17].
To highlights, RAAS and vitamin D share its evolu-
tionary origin, the ubiquity in many cells, and tissues such
as the lungs. However, our group described an inverse
relationship in both healthy in the disease conditions [18].
Some studies show that AA people present an imbal-
ance between ACE/ACE2 as a consequence of overactivity
of the RAAS pressor arm (ACE/Ang II/AT1 receptor) and
lower activity in the RAAS depressor axis (ACE2/Ang-
(1–7)/Mas receptor), reducing ACE2 activity. The level
of ACE2 in different tissues, especially in the lungs- seems
to be crucial for the susceptibility, development, and
progression for hypertension, cardiovascular risk, and
pulmonary viral diseases as SARS-CoV-2 infection. There
is experimental evidence that SARS-CoV-2 uses ACE2
receptors and the serine protease TMPRSS2 to enter the
pulmonary cells trapping and downregulates ACE2
receptors reducing its activity [11]. The preservation of the
integrity and functionality of the ACE2 receptor is asso-
ciated and seems to be essential against viral infections and
the maintenance of an adequate lung function. RAAS
inhibition and vitamin D supplementation increase ACE2
levels and restore the ACE/ACE2 balance. Multiple stu-
dies showed that vitamin D antagonizes RAAS effects,
especially by the reduction in the inflammatory response
[19]. Furthermore, basic, epidemiological, and clinical
research reinforces the idea that vitamin D protects from
severe viral infections. Despite the lack of studies to define
the adequate level of vitamin D to protect against viral
infection, we agree with Grant et al., and estimate that a
range between 40 and 60 mg/dL and the recommended
dose to achieve this, between 5000 and 10,000 IU/day for
several weeks [14].
Consequently, as is summarized in figure, our letter aims
to generate discussion addressing plausible use of high
doses of vitamin D in the AA population as a protective
strategy in COVID-19 against both virus entrance, inflam-
matory storm, and inclusive, the death. As was proposed for
other high-risk populations, and currently are ongoing at list
ten randomized controlled trials [20], it is necessary to
know whether vitamin D supplementation could be useful
in the prevention and treatment of COVID-19 in the AA
population.
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